Innovations in Pharmaceutical Technology

Summer is upon us, and with the warm weather comes inspiration for innovations in all areas, particularly pharmtech. This edition of IPT includes fascinating discussions around manufacturing different materials for pharma treatments, such as synthetic DNA (4basebio, page 14) and gene therapies (FinVector Oy, page 18), and how the sector can improve green ideas to ensure more sustainable production (Syntegon Technology, page 22).

There are also conversations concerning emerging discovery and development techniques, and the difference between ligand-based and structure-based approaches (Optibrium, page 29). BioSynth put forward the use of N-acetylgalactosamine conjugates for the use of liver-targeted therapies (page 33).

Digital innovations are permeating pharma technology. Watlow discusses real-time qualification and how it is ensuring compliance in life sciences (page 40), while Chemical AI highlights retrosynthesis and how artificial intelligence is transforming the field (page 46).

Lab design and management is often overlooked or taken for granted, but ensuring the lab is as functional as possible can speed up processes, ultimately bringing therapies to patients faster. Azenta Life Sciences puts forward the need for improved ultra-low storage (page 50) and Elemental Machines offers some tips as to equipment utilisation and asset management (page 54).

IPT Summer also features the INTERPHEX 2025 event review – an in-depth look into the premier event for pharmaceutical and biotechnology professionals (page 25).

We hope you enjoy IPT Summer, and look forward to welcoming you back for Autumn later in the year!